Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast.
encapsulated papillary carcinoma
encapsulated papillary carcinoma with invasion
intraductal papilloma
invasive solid papillary carcinoma
papillary breast lesions
papillary dcis
papilloma with atypical ductal hyperplasia (adh)
papilloma with ductal carcinoma in situ (dcis)
solid papillary carcinoma in situ
solid papillary carcinoma with invasion
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
18 Oct 2020
18 Oct 2020
Historique:
entrez:
20
11
2020
pubmed:
21
11
2020
medline:
21
11
2020
Statut:
epublish
Résumé
Introduction Papillary breast lesions are segregated into benign and malignant based on the presence or absence of myoepithelial cells in the papillary cores. Papillary breast lesions are further classified into: intraductal papilloma, papilloma with atypical ductal hyperplasia (ADH)/ductal carcinoma in situ (DCIS), papillary DCIS, solid papillary carcinoma in situ, solid papillary carcinoma with invasion, invasive solid papillary carcinoma, encapsulated papillary carcinoma and encapsulated papillary carcinoma with invasion. In this study, we evaluated the spectrum of papillary breast lesions in resection specimens of the breast according to the latest World Health Organization (WHO) classification of breast tumors. Methods This was a retrospective cross-sectional study, and was conducted at Liaquat National Hospital for a period of six years, from January 2012 till December 2017. Data of patients that underwent surgeries for breast tumors were included in the study. All specimens were grossed, according to defined protocols, and representative sections were taken after inking resection margins. Hematoxylin and eosin-stained sections were examined by experienced histopathologists, and myoepithelial stains (p63 and myosin) were done in selected sections of all tumors. Histopathological classification of papillary tumors was performed according to WHO classification of breast tumors. Results The study involved 190 excision specimens of papillary breast lesions. Mean age of the patients was 45.6±17.1 years. Most of the lesions were between two and five centimetres (69.1%). For invasive carcinomas (n = 76), the most frequent grade was II (52.6%). For in situ and invasive carcinomas (n = 129), lymphovascular invasion and axillary metastasis were noted in 5.4% and 9.3% cases, respectively. Among papillary breast lesions, 36.8% were benign (intraductal papilloma, solitary or multiple) while 63.2% harbored ADH, DCIS, or invasive carcinoma. Invasive papillary carcinoma was the most frequent malignant papillary lesion (20%), followed by solid papillary carcinoma with invasion (12.6%). We found significant associations between patient's age and tumor size with histological type of papillary lesion as benign papillary lesions had smaller size and younger age compared to malignant papillary lesions. Conclusion We noted a high frequency of malignancy in papillary breast lesions. Moreover, malignant papillary lesions were significantly associated with higher age and larger tumor size.
Identifiants
pubmed: 33214954
doi: 10.7759/cureus.11026
pmc: PMC7671300
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e11026Informations de copyright
Copyright © 2020, Hashmi et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Diagn Pathol. 2014 Feb 28;9:43
pubmed: 24581278
Breast Cancer Res Treat. 1984;4(2):117-28
pubmed: 6743838
Arch Pathol Lab Med. 2009 Jun;133(6):893-907
pubmed: 19492881
Arch Pathol Lab Med. 2016 Jul;140(7):628-43
pubmed: 27362568
Asian Pac J Cancer Prev. 2013;14(7):4353-8
pubmed: 23992002
Oncol Res Treat. 2018;41(1-2):29-34
pubmed: 29402800
Breast. 2011 Dec;20(6):501-4
pubmed: 21640590
Acta Med Litu. 2018;25(2):66-75
pubmed: 30210240
Breast J. 2014 Nov-Dec;20(6):578-85
pubmed: 25219294
BMC Res Notes. 2018 Jul 31;11(1):531
pubmed: 30064485
Am J Surg Pathol. 2016 Oct;40(10):1334-42
pubmed: 27438988
Histopathology. 2015 May;66(6):761-70
pubmed: 24845113
World J Surg Oncol. 2018 Jan 2;16(1):1
pubmed: 29291744